⌘K

Login Start Free

Home/Filings/4/0001209191-21-068113

4//SEC Filing

Zinda Michael 4

Accession 0001209191-21-068113

CIK 0001808158other

View on SEC.gov Company Profile

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 4:47 PM ET

Size

18.7 KB

Accession

0001209191-21-068113

Insider Transaction Report

Form 4

Period: 2021-11-23

Repare Therapeutics Inc.RPTX

EVP, CHIEF SCIENTIFIC OFFICER

Transactions

Exercise/Conversion
Common Shares
2021-11-23$1.64/sh+4,122$6,748→ 4,655 total
Exercise/Conversion
Common Shares
2021-11-23$2.06/sh+19,590$40,395→ 36,101 total
Exercise/Conversion
Employee Stock Option (right to buy)
2021-11-23−4,122→ 0 total
Exercise: $1.64Exp: 2027-06-14→ Common Shares (4,122 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2021-11-23−19,590→ 35,260 total
Exercise: $2.06Exp: 2029-03-29→ Common Shares (19,590 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2021-11-23−10,473→ 137,993 total
Exercise: $2.42Exp: 2029-12-16→ Common Shares (10,473 underlying)
Exercise/Conversion
Common Shares
2021-11-23$1.64/sh+11,856$19,408→ 16,511 total
Exercise/Conversion
Common Shares
2021-11-23$2.42/sh+10,473$25,397→ 46,574 total
Exercise/Conversion
Employee Stock Option (right to buy)
2021-11-23−11,856→ 0 total
Exercise: $1.64Exp: 2027-12-04→ Common Shares (11,856 underlying)

Footnotes (3)

[F1]Fully vested and exercisable.
[F2]Twenty-five percent (25%) of the shares subject to the option vested on March 29, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
[F3]Twenty-five percent (25%) of the shares subject to the option vested on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Repare Therapeutics Inc.

CIK 0001808158

Entity typeother

Related Parties

1

filerCIK 0001815366

Filing Metadata

Form type: 4
Filed: Dec 5, 7:00 PM ET
Accepted: Dec 6, 4:47 PM ET
Size: 18.7 KB

View on SEC.gov